Electra City Tower
58 Harakevet St.
Tel Aviv
6777016
Misha Gitterman
Misha is a partner in the firm's Capital Markets Department.
Adv. Misha Gitterman has over 30 years of experience providing representation in corporate financing transactions, mergers and acquisitions, and investment transactions, both local and international.
Misha represents private equity funds, venture capital funds, and institutional investors in a wide range of complex transactions.
In addition, Misha represents clients operating in a variety of business areas. He advises on all aspects of their business and corporate activities, with a special emphasis on guiding startups throughout the stages of their development, including and especially with regard to raising private and public funding.
Misha also has special expertise in representing investors and technology ventures for the elderly. Along with his rich legal experience, Misha worked for many years as a senior manager in an investment and public holding company and as a director in private and public companies. Misha is a member of the National Board of Directors, elected by the Government Companies Authority.
Prominent legal directory The Legal 500 ranks Misha in the Banking & Finance practice area.
Education:
Tel Aviv University, LL.B., 1995
Tel Aviv University, B.A. in Economics, 1995
Admission:
Israel Bar Association, 1996
Insights & News - Misha Gitterman:
Amy Group Signs ILS 350 Million Strategic Investment Agreement with Migdal
Our firm is advising Amy Group on a strategic investment agreement with Migdal Insurance and Financial Holdings, under which Migdal will extend ILS 350 million in credit to Amy Group. Adv. Misha Gitterman advised Amy Group, which is controlled by Shlomi Nehiesi, on the transaction. The agreement supports Amy Group's growth strategy in the commercial and income-producing real estate sectors. Under the agreement, Migdal will receive options to acquire 10% of Amy Group's shares, which will be issued upon the company's IPO.
Representing Artivion in USD 375 Million Acquisition
We represent Artivion, Inc., a publicly traded US medical device company (NYSE: AORT) focused on cardiac and vascular surgery products. The company engaged us to advise on its acquisition of the Israeli company Endospan. Adv. Micky Barnea, Adv. Misha Gitterman, and Adv. Tal Freilich Hay led the representation.